DRDorota Ruszkiewicz

Dorota Ruszkiewicz

*This is an algorithmically generated author record based on publicly available information.

Dorota Ruszkiewicz has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Benchmarking breath analysis using peppermint approach with gas chromatography ion mobility spectrometer coupled to micro thermal desorber

    by Dorota M Ruszkiewicz, Kristian J Kiland, Yoonseo Mok, Crista Bartolomeu, Scott A Borden, Paul Thomas, Stephen Lam, Renelle Myers

    The Peppermint Initiative, established within the International Association of Breath Research, introduced the peppermint protocol, a breath analysis benchmarking effort designed to address the lack of inter-comparability of outcomes across different breath sampling techniques and analytical platforms. Benchmarking with gas chromatography—ion mobility spectrometry (GC-IMS) using peppermint has been previously reported however, coupling micro-thermal desorption (µTD) to GC-IMS has not yet, been benchmarked for breath analysis. To benchmark µTD-GC-IMS for breath analysis using the peppermint protocol. Ten healthy participants (4 males and 6 females, aged 20–73 years), were enrolled to give six breath samples into Nalophan bags via a modified peppermint protocol. Breath sampling after peppermint ingestion occurred over 6 h at t = 60, 120, 200, 280, and 360 min. The breath samples (120 cm3) were pre-concentrated in the µTD before being transferred into the GC-IMS for detection. Data was processed using VOCal, including background subtractions, peak volume measurements, and room air assessment. During peppermint washout, eucalyptol showed the highest change in concentration levels, followed by α-pinene and β-pinene. The reproducibility of the technique for breath analysis was demonstrated by constructing logarithmic washout curves, with the average linearity coefficient of R 2 = 0.99. The time to baseline (benchmark) value for the eucalyptol washout was 1111 min (95% CI: 529–1693 min), obtained by extrapolating the average logarithmic washout curve. The study demonstrated that µTD-GC-IMS is reproducible and suitable technique for breath analysis, with benchmark values for eucalyptol comparable to the gold standard GC-MS.


  • Open Access

    Peppermint protocol: first results for gas chromatography-ion mobility spectrometry

    by Dorota M Ruszkiewicz, Renelle Myers, Ben Henderson, Hazim Yusof, Austin Meister, Sergi Moreno, Michael Eddleston, Kareen Darnley, William H Nailon, Duncan McLaren, et al.

    The Peppermint Initiative seeks to inform the standardisation of breath analysis methods. Five Peppermint Experiments with gas chromatography-ion mobility spectrometry (GC-IMS), operating in the positive mode with a tritium 3H 5.68 keV, 370 MBq ionisation source, were undertaken to provide benchmark Peppermint Washout data for this technique, to support its use in breath-testing, analysis, and research. Headspace analysis of a peppermint-oil capsule by GC-IMS with on-column injection (0.5 cm3) identified 12 IMS responsive compounds, of which the four most abundant were: eucalyptol; β-pinene; α-pinene; and limonene. Elevated concentrations of these four compounds were identified in exhaled-breath following ingestion of a peppermint-oil capsule. An unidentified compound attributed as a volatile catabolite of peppermint-oil was also observed. The most intense exhaled peppermint-oil component was eucalyptol, which was selected as a peppermint marker for benchmarking GC-IMS. Twenty-five washout experiments monitored levels of exhaled eucalyptol, by GC-IMS with on-column injection (0.5 cm3), at t = 0 min, and then at t + 60, t + 90, t + 165, t + 285 and t + 360 min from ingestion of a peppermint capsule resulting in 148 peppermint breath analyses. Additionally, the Peppermint Washout data was used to evaluate clinical deployments with a further five washout tests run in clinical settings generating an additional 35 breath samples. Regression analysis yielded an average extrapolated time taken for exhaled eucalyptol levels to return to baseline values to be 429 ± 62 min (±95% confidence-interval). The benchmark value was assigned to the lower 95% confidence-interval, 367 min. Further evaluation of the data indicated that the maximum number of volatile organic compounds discernible from a 0.5 cm3 breath sample was 69, while the use of an in-line biofilter appeared to reduce this to 34.


  • Open Access

    Breath collection protocol for SARS-CoV-2 testing in an ambulatory setting

    by Renelle Myers, Dorota Ruskiewicz, Austin Meister, Atkar Khattra Sukhinder, Crista Bartolomeu, Paul Thomas, Stephen Lam

    Background. The SARS-CoV-2 pandemic changed the way the society functioned. The race to develop a rapid, non-invasive, widely available test resulted in multiple studies examining the potential of breath to be that ‘game changing test’. Breath sampling is a non-invasive point of care test, but SAR-CoV-2 has introduced a level of danger into collection and analysis that requires a change in workflow to keep staff and participants safe. We developed a SARS-CoV 2 breath test work flow for collection and processing of breath samples in an ambulatory care setting and prospectively evaluated the protocol. Protocol development included testing the effect of respiratory filters on the integrity and reproducibility of breath samples. Methods. Prospective, observational study conducted at community COVID-19 testing sites, collecting breath samples from patients presenting for RT-PCR testing. Breath was collected via Tedlar®, and/or BioVOC-2™ as well as an environmental sample for all participants. Samples were transferred to Tenex tubes, dry purged and analyzed using a Centri automated sample introduction machine, GC, and a Bench-ToF-HD. Results. We successfully collected and processed 528 breath samples from 393 participants at community-based ambulatory COVID-19 test sites. The majority of samples were collected before vaccines were available and throughout the emergence of the Delta Variant. No staff member was infected. Conclusion. We demonstrated a safe workflow for the collection, handling, transport, storage, and analysis of breath samples during the pandemic collecting highly infectious SARS-CoV-2 positive breath samples. This was done without filters as they added complexity to the breath matrix, jeopardizing the sample integrity.


  • Open Access

    The variability of volatile organic compounds in the indoor air of clinical environments

    by Dahlia Salman, Wadah Ibrahim, Amisha Kanabar, Abigail Joyce, Bo Zhao, Amisha Singapuri, Michael Wilde, Rebecca L Cordell, Teresa McNally, Dorota Ruszkiewicz, et al.

    The development of clinical breath-analysis is confounded by the variability of background volatile organic compounds (VOCs). Reliable interpretation of clinical breath-analysis at individual, and cohort levels requires characterisation of clinical-VOC levels and exposures. Active-sampling with thermal-desorption/gas chromatography-mass spectrometry recorded and evaluated VOC concentrations in 245 samples of indoor air from three sites in a large National Health Service (NHS) provider trust in the UK over 27 months. Data deconvolution, alignment and clustering isolated 7344 features attributable to VOC and described the variability (composition and concentration) of respirable clinical VOC. 328 VOC were observed in more than 5% of the samples and 68 VOC appeared in more than 30% of samples. Common VOC were associated with exogenous and endogenous sources and 17 VOC were identified as seasonal differentiators. The presence of metabolites from the anaesthetic sevoflurane, and putative-disease biomarkers in room air, indicated that exhaled VOC were a source of background-pollution in clinical breath-testing activity. With the exception of solvents, and waxes associated with personal protective equipment (PPE), exhaled VOC concentrations above 3 µg m−3 are unlikely to arise from room air contamination, and in the absence of extensive survey-data, this level could be applied as a threshold for inclusion in studies, removing a potential environmental confounding-factor in developing breath-based diagnostics.


  • Open Access

    Breath markers for therapeutic radiation

    by Dahlia Salman, Michael Eddleston, Kareen Darnley, William H. Nailon, Duncan B. McLaren, Andria Hadjithelki, Dorota Ruszkiewicz, Jens Langejuergen, Yaser Alkhalifa, Iain Phillips, et al.

    We read with much interest the letter by Tuscano et al. [ [1] Tuscano C, Sceni G, Sayyad S Al. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled “50 years of radiotherapy research: Evolution, trends and lessons for the future“ by Berger et al. Radiother Oncol 2022. Google Scholar ] relating to our analysis of 50 years of PubMed records on Radiotherapy [ [2] Berger T. Noble D.J. Shelley L.E.A. Hopkins K.I. McLaren D.B. Burnet N.G. et al. 50 years of radiotherapy research: Evolution, trends and lessons for the future. Radiother Oncol. 2021; 165 : 75-86 https://doi.org/10.1016/J.RADONC.2021.09.026/ATTACHMENT/C3D14F73-7E99-4A4C-92AF-1DE741CBFA2F/MMC3.TXT Google Scholar ] and thank them for sharing their reflections on how to rebalance and further develop our discipline in the future. We share their views on the importance of the role to be played by biology to achieve improved personalisation of Radiotherapy treatments, which they neatly encapsulated in the term dose painting by bio-features. More specifically, we strongly believe that incorporating patient-specific biological information such as, tumour and normal tissue radio-sensitivity [ 3 Salman D. Eddleston M. Darnley K. Nailon W.H. McLaren D.B. Hadjithelki A. et al. Breath markers for therapeutic radiation. J Breath Res. 2020; 15 https://doi.org/10.1088/1752-7163/ABA816 Google Scholar , 4 Meehan J. Gray M. Martínez-Pérez C. Kay C. Pang L.Y. Fraser J.A. et al. Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer. Front Oncol. 2020; 10 : 628 https://doi.org/10.3389/FONC.2020.00628/BIBTEX Google Scholar , 5 Kerns S.L. Fachal L. Dorling L. Barnett G.C. Baran A. Peterson D.R. et al. Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. JNCI J Natl Cancer Inst. 2020; 112 : 179-190 Google Scholar ] either evaluated pre-treatment via radio-genomics for instance, or in vivo via imaging and radiomic analysis [ 6 Cheng K. Montgomery D. Feng Y. Steel R. Liao H. McLaren D.B. et al. Identifying radiotherapy target volumes in brain cancer by image analysis. Healthc Technol Lett. 2015; 2 : 123-128 Google Scholar , 7 Feng Y. Welsh D. McDonald K. Carruthers L. Cheng K. Montgomery D. et al. Identifying the dominant prostate cancer focal lesion using image analysis and planning of a simultaneous integrated stereotactic boost. Http://DxDoiOrg/103109/0284186X20151063782. 2015; 54 : 1543-1550 Google Scholar ], is a promising strategy which will ultimately translate into clinical benefits for patients [ [8] Scaife J.E. Barnett G.C. Noble D.J. Jena R. Thomas S.J. West C.M.L. et al. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015; 88 : 20150172 Google Scholar ].


  • Open Access

    A benchmarking protocol for breath analysis: the peppermint experiment

    by Ben Henderson, Dorota M Ruszkiewicz, Max Wilkinson, Jonathan D Beauchamp, Simona M Cristescu, Stephen J Fowler, Dahlia Salman, Fabio Di Francesco, Gudrun Koppen, Jens Langejürgen, et al.

    Sampling of volatile organic compounds (VOCs) has shown promise for detection of a range of diseases but results have proved hard to replicate due to a lack of standardization. In this work we introduce the ‘Peppermint Initiative’. The initiative seeks to disseminate a standardized experiment that allows comparison of breath sampling and data analysis methods. Further, it seeks to share a set of benchmark values for the measurement of VOCs in breath. Pilot data are presented to illustrate the standardized approach to the interpretation of results obtained from the Peppermint experiment. This pilot study was conducted to determine the washout profile of peppermint compounds in breath, identify appropriate sampling time points, and formalise the data analysis. Five and ten participants were recruited to undertake a standardized intervention by ingesting a peppermint oil capsule that engenders a predictable and controlled change in the VOC profile in exhaled breath. After collecting a pre-ingestion breath sample, five further samples are taken at 2, 4, 6, 8, and 10 h after ingestion. Samples were analysed using ion mobility spectrometry coupled to multi-capillary column and thermal desorption gas chromatography mass spectrometry. A regression analysis of the washout data was used to determine sampling times for the final peppermint protocol, and the time for the compound measurement to return to baseline levels was selected as a benchmark value. A measure of the quality of the data generated from a given technique is proposed by comparing data fidelity. This study protocol has been used for all subsequent measurements by the Peppermint Consortium (16 partners from seven countries). So far 1200 breath samples from 200 participants using a range of sampling and analytical techniques have been collected. The data from the consortium will be disseminated in subsequent technical notes focussing on results from individual platforms.


  • Breath selection methods for compact mass spectrometry breath analysis

    by Kerry Rosenthal, Dorota M Ruszkiewicz, Hayden Allen, Martin R Lindley, Matthew A Turner, Eugenie Hunsicker

    Compact mass spectrometry (CMS) is a versatile and transportable analytical instrument that has the potential to be used in clinical settings to quickly and non-invasively detect a wide range of relevant conditions from breath samples. The purpose of this study is to optimise data preprocessing protocols by three proposed methods of breath sampling, using the CMS. It also lays out a general framework for which data processing methods can be evaluated. Methods. This paper considers data from three previous studies, each using a different breath sampling method. These include a peppermint washout study using continuous breath sampling with a purified air source, an exercise study using continuous breath sampling with an ambient air source, and a single breath sampling study with an ambient air source. For each dataset, different breath selection (data preprocessing) methods were compared and benchmarked according to predictive performance on a validation set and quantitative reliability of m / z bin intensity measurements. Results. For both continuous methods, the best breath selection method improved the predictive model compared to no preselection, as measured by the 95% CI range for Youden’s index, from 0.68–0.86 to 0.86–0.97 for the exercise study and 0.69–0.82 to 1.00–1.00 for the peppermint study. The reliability of intensity measurements for both datasets (as measured by median relative standard deviation (RSD)), was improved slightly by the best selection method compared to no preselection, from 18% to 14% for the exercise study and 7%–5% for the peppermint study. For the single breath samples, all the models resulted in perfect prediction, with a 95% CI range for Youden’s index of 1.00–1.00. The reliability of the proposed method was 38%. Conclusion. The method of selecting exhaled breath from CMS data can affect the reliability of the measurement and the ability to distinguish between breath samples taken under different conditions. The application of appropriate data processing methods can improve the quality of the data and results obtained from CMS. The methods presented will enable untargeted analysis of breath VOCs using CMS to be performed.